HarishGAhujaMD

PubMed

• Reply to The effects of curative-intent cancer therapy on employment, work ability, and work limitations
  Amye J. Tevaarwerk, Kris Kwekkeboom, Kevin A. Buhr, Alexandra Dennee, William Conkright, Adedayo A. Onitilo, Emily Robinson, Harish Ahuja, Roger W. Kwong, Ranveer Nana...> ;Cancer. 2021 Aug 15
• 8 citations
  Results from a prospective longitudinal survey of employment and work outcomes in newly diagnosed cancer patients during and after curative-intent chemotherapy: A Wisc...
  Amye J. Tevaarwerk, Kris Kwekkeboom, Kevin A. Buhr, Alexandra Dennee, William Conkright, Adedayo A. Onitilo, Emily Robinson, Harish Ahuja, Roger W. Kwong, Ranveer Nana...> ;Cancer. 2021 Mar 1
• 35 citations
  A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study
  Timothy S. Fenske, Namrata Shah, Kyung Mann Kim, Sandeep Saha, Chong Zhang, Arielle Baim, John P. Farnen, Adedayo A. Onitilo, Jules H. Blank, Harish Ahuja, Tim Wassena...> ;Cancer. 2015 Oct 1
• 29 citations
  Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study
  Tien Hoang, Toby C. Campbell, Chong Zhang, KyungMann Kim, Jill M. Kolesar, Kurt R. Oettel, Jules H. Blank, Emily Robinson, Harish Ahuja, Ron J. Kirschling, Peter H. Jo...> ;Investigational New Drugs. 2014 Feb 1
• Vorinostat (V) and bortezomib (B) as third-line treatment in patients with advanced non-small cell lung cancer (NSCLC): A Wisconsin Oncology Network Phase II Study.
  Jones MW, Zhang C, Oettel KR, Blank JH, Robinson EG, Ahuja HG, Kirschling RJ, Johnson PH, Huie MS, Kolesar J, Wims MB, Hernan H, Campbell TC, Traynor AM, Hoang T> ;J. Clin. Oncol.. 2011-05-20
• A phase II consortium trial of vorinostat and bortezomib for advanced soft tissue sarcomas.
  Attia S, Mahoney MR, Okuno SH, Adkins D, Ahuja HG, Ducker TP, Maples WJ, Ochs L, Wentworth-Hartung NL, Erlichman C, Bailey HH> ;J. Clin. Oncol.. 2011-05-20
• 8 citations
  Electronic brachytherapy as adjuvant therapy for early stage breast cancer: a retrospective analysis
  William C. Dooley, James C Wurzer, Mohamed Megahy, Gary Schreiber, Tapan Roy, Gary M. Proulx, Susan J. Laduzinsky, Steven C. Lane, James Dalzell, Kambiz Dowlatshahi, D...> ;Oncotargets and Therapy. 2011 Jan 12
• 7 citations
  Use of electronic brachytherapy to deliver postsurgical adjuvant radiation therapy for endometrial cancer: a retrospective multicenter study
  William C. Dooley, John P Thropay, Gary Schreiber, Mohamed Y Puthawala, Steven C. Lane, James C Wurzer, Charles E Stewart, Gordon L Grado, Harish G Ahuja, Gary M. Proulx> ;Oncotargets and Therapy. 2010 Oct 5
• 25 citations
  Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network study
  Julie E. Chang, P M Voorhees, Jill M. Kolesar, Harish Ahuja, F A Sanchez, G A Rodriguez, KyungMann Kim, Jae Werndli, Howard H. Bailey, Brad S. Kahl> ;Hematological Oncology. 2009 Mar 1
• 2 citations
  Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology ne...
  Steven Attia, Anne M. Traynor, KyungMann Kim, Joseph Merchant, Tien Hoang, Harish Ahuja, Peter A. Beatty, Richard M. Hansen, Gregory A. Masters, Kurt R. Oettel, Gary R...> ;Journal of Thoracic Oncology. 2008 Sep 1
• 44 citations
  Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer
  Steven Attia, Jens C. Eickhoff, George Wilding, Douglas G. McNeel, Jules H. Blank, Harish Ahuja, Alcee Jumonville, Michael Eastman, Daniel H. Shevrin, Michael Glode, D...> ;Clinical Cancer Research. 2008 Apr 15
• 6 citations
  Phase I/II Study of Gemcitabine and Exisulind as Second-Line Therapy in Patients with Advanced Non–small Cell Lung Cancer
  Tien Hoang, KyungMann Kim, Joseph Merchant, Anne M. Traynor, James McGovern, Kurt R. Oettel, Fredrico A. Sanchez, Harish Ahuja, Thomas A. Hensing, Martha M. Larson, Jo...> ;Journal of Thoracic Oncology. 2006 Mar 1
• 8 citations
  A phase II trial of gemcitabine, 5-fluorouracil and leucovorin in advanced esophageal carcinoma.
  Sherry Morgan-Meadows, Daniel Mulkerin, Jordan Berlin, KyungMann Kim, Howard H. Bailey, Thomas J. Saphner, Alcee Jumonville, Richard M. Hansen, Harish Ahuja, Thomas Mc...> ;Oncology. 2005 Jan 1
• Phase I/II study of exisulind and gemcitabine in patients with recurrent advanced non-small cell lung cancer (NSCLC).
  Hoang T, Kim K, Merchant J, Traynor AM, Ahuja HG, Masters GA, McGovern JD, Oettel KR, Sanchez FA, Schiller JH> ;J. Clin. Oncol.. 2004-07-15
• Phase I/II study of exisulind (E) and vinorelbine (V) in elderly patients with advanced non-small cell lung cancer (NSCLC).
  Traynor AM, Merchant JJ, Hoang T, Ahuja HG, Beatty PA, Hansen RM, Masters GA, Oettel KR, Shapiro GR, Schiller JH> ;J. Clin. Oncol.. 2004-07-15
• 52 citations
  NUP98 gene rearrangements and the clonal evolution of chronic myelogenous leukemia.
  Harish G. Ahuja, Leslie Popplewell, Lucene Tcheurekdjian, Marilyn L. Slovak> ;Genes, Chromosomes & Cancer. 2001 Apr 1
• 75 citations
  t(9;11)(p22;p15) in Acute Myeloid Leukemia Results in a Fusion between NUP98 and the Gene Encoding Transcriptional Coactivators p52 and p75-Lens Epithelium-derived Gro...
  Harish G. Ahuja, Jianming Hong, Peter D. Aplan, Lucene Tcheurekdjian, Stephen J. Forman, Marilyn L. Slovak> ;Cancer Research. 2000 Nov 15
• 46 citations
  Potential role for DNA topoisomerase II poisons in the generation of t(11;20)(p15;q11) translocations.
  Harish G. Ahuja, Carolyn A. Felix, Peter D. Aplan> ;Genes, Chromosomes & Cancer. 2000 Oct 1
• 83 citations
  The t(11;20)(p15;q11) chromosomal translocation associated with therapy-related myelodysplastic syndrome results in an NUP98-TOP1 fusion.
  Harish G. Ahuja, Carolyn A. Felix, Peter D. Aplan> ;Blood. 1999 Nov 1
• Join now to see all